Dr Krimholtz - Treatment options OADs and insulins
About the event
Dr. Krimholtz presents a complete revision about the importance of an early glycemic control and the legacy effect associated to an intensive glucose lowering therapy. You will find an overview of the different therapeutical classes present in the market, such as: New generation Sulfonylureas, Metformin, DPP4i, SGLT2i, a-GLP1 and Insulins, along with an analysis of the evidence they have.
It can also interest you
Don't miss our next events!
Subscribe to our newsletter to receive invitations to upcoming events